Empirico Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $45.2M

  • Investors
  • 5

Empirico General Information

Description

Developer of an insights platform designed to turn biological insights from human genetics into new medicines. The company's platform uses biological datasets, human genetics and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate and prioritize high-confidence therapeutic hypotheses.

Contact Information

Website
www.empiri.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4660 La Jolla Village Drive
  • Suite 100
  • San Diego, CA 92122
  • United States
+1 (347)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 4660 La Jolla Village Drive
  • Suite 100
  • San Diego, CA 92122
  • United States
+1 (347)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Empirico Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 20-Mar-2023 $45.2M Completed Generating Revenue
2. Early Stage VC (Series A2) 20-Dec-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Nov-2018 $12.5M $12.5M Completed Generating Revenue
To view Empirico’s complete valuation and funding history, request access »

Empirico Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-1
Series B
Series A2
Series A1 426,540 $0.000010 $0.1 $1.29 $1.29 1x $1.29 1.09%
Series A 7,445,092 $0.000010 $0.13 $1.61 $1.61 1x $1.61 19.1%
To view Empirico’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Empirico Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an insights platform designed to turn biological insights from human genetics into new medicines. The compa
Drug Discovery
San Diego, CA
78 As of 2024

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Empirico Competitors (1)

One of Empirico’s competitors is Genoox, a Private Equity-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genoox Private Equity-Backed Palo Alto, CA
You’re viewing 1 of 1 competitors. Get the full list »

Empirico Patents

  • 67

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 52

    Pending

  • Expiring in next 12 mo

Empirico Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240392296-A1 Treatment of mst1 related diseases and disorders Pending 15-Dec-2022
US-20230304008-A1 Modified oligonucleotides Pending 28-Mar-2022
AU-2023245603-A1 Modified oligonucleotides Pending 28-Mar-2022
EP-4499111-A2 Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases Pending 28-Mar-2022
EP-4499834-A2 Modified oligonucleotides Pending 28-Mar-2022 C12N15/113
To view Empirico’s complete patent history, request access »

Empirico Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Empirico Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AbCellera Corporation Minority
Qiming Venture Partners USA Venture Capital Minority
Ionis Pharmaceuticals Corporation Minority
DCVC Bio Venture Capital Minority
Neotribe Ventures Venture Capital Minority
To view Empirico’s complete investors history, request access »

Ready to get started?

Request a free trial

Empirico FAQs

  • When was Empirico founded?

    Empirico was founded in 2017.

  • Where is Empirico headquartered?

    Empirico is headquartered in San Diego, CA.

  • What is the size of Empirico?

    Empirico has 78 total employees.

  • What industry is Empirico in?

    Empirico’s primary industry is Drug Discovery.

  • Is Empirico a private or public company?

    Empirico is a Private company.

  • What is the current valuation of Empirico?

    The current valuation of Empirico is .

  • What is Empirico’s current revenue?

    The current revenue for Empirico is .

  • How much funding has Empirico raised over time?

    Empirico has raised $74.8M.

  • Who are Empirico’s investors?

    AbCellera, Qiming Venture Partners USA, Ionis Pharmaceuticals, DCVC Bio, and Neotribe Ventures have invested in Empirico.

  • Who are Empirico’s competitors?

    Genoox is a competitor of Empirico.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »